Home › Funds › BVF INC/IL › KYMR

BVF INC/IL position in KYMR

KYMERA THERAPEUTICS INC · Health Care

BVF INC/IL reported holding 3,872,052 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$444.0M, representing 11.35% of its reported portfolio and ranking #2 among its reported holdings. BVF INC/IL has disclosed KYMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.87M sh
Reported value held$444.01M
Portfolio Weight11.35%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's KYMR position evolved

BVF INC/IL first disclosed a stake in KYMR in Q3 2023 at 4,739,004 shares (US$65.9M). The position peaked in Q1 2026 at 5,502,710 shares, worth US$458.3M. Across 12 filings, BVF INC/IL increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 3,872,052 shares valued at US$444.0M — a reduction of -1,630,658 shares quarter over quarter.. Notable position changes include a 30% trim in Q2 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.74M $65.87M New
Q4 2023 5.16M $131.42M Add
Q1 2024 5.16M $207.50M Hold
Q2 2024 5.16M $154.08M Hold
Q3 2024 5.16M $244.31M Hold
Q4 2024 5.16M $207.66M Hold
Q1 2025 5.16M $141.28M Hold
Q2 2025 5.50M $240.14M Add
Q3 2025 5.50M $311.45M Hold
Q4 2025 5.50M $428.17M Hold
Q1 2026 5.50M $458.32M Hold
Q2 2026 3.87M $444.01M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KYMR and 13F data

KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KYMR

All KYMR fund holders →

FAQ

How long has BVF INC/IL held KYMR?

BVF INC/IL has disclosed KYMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BVF INC/IL's current position in KYMR?

As of Q2 2026, BVF INC/IL holds 3.87M shares of KYMR (KYMERA THERAPEUTICS INC), valued at $444.01M, representing 11.35% of its reported portfolio and ranking #2.

Has BVF INC/IL been buying or selling KYMR?

In the latest 13F filing (Q2 2026), BVF INC/IL reduced its position in KYMR. The position peaked in Q1 2026 at 5.50M shares.

Which other funds hold KYMR?

Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.